Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach

This publication has 29 references indexed in Scilit:

• A Semiparametric Response Surface Model for Assessing Drug Interaction
  Biometrics, 2008
• Interactions between drugs and occupied receptors
  Pharmacology & Therapeutics, 2007
• An Overview of Drug Combination Analysis with Isobolograms
  The Journal of Pharmacology and Experimental Therapeutics, 2006
• Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels
  Molecular Cancer Therapeutics, 2006
• Towards a mechanism-based analysis of pharmacodynamic drug?drug interactions in vivo
  Pharmacology & Therapeutics, 2004
• The combination of yondelis and cisplatin is synergistic against human tumor xenografts
  European Journal Of Cancer, 2003
• Didanosine, interferon-alfa and ribavirin
  AIDS, 2003
• Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs
  Oncogene, 1998
• A three-dimensional model to analyze drug-drug interactions
  Antiviral Research, 1990
• Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
  Advances in Enzyme Regulation, 1984